Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients — Su Yin Lim (2017) | RDL Network
Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients
Article 2017 en
Authors
SL
Su Yin Lim
JL
Jenny Lee
SW
Sarah J. Welsh
Abstract
1 min read
Our study highlights significant limitations imposed by inconsistent sensitivity and specificity due to differences in the detection antibodies or aptamers of these widespread biomarker discovery approaches. Our findings emphasize the need to improve these technologies for the accurate identification of biomarkers.
Su Lim, Jenny Lee, Sarah J. Welsh, Seong Ahn, Edmond J. Breen, Alamgir Khan, Matteo S. Carlino, Alexander M. Menzies, Richard Kefford, Richard A Scolyer, Georgina Long, Helen Rizos
Su Lim, Jenny Lee, Sarah J. Welsh, Seong Ahn, Edmond J. Breen, Alamgir Khan, Matteo S. Carlino, Alexander M. Menzies, Richard Kefford, Richard A Scolyer, Georgina Long, Helen Rizos
Lorena Vázquez‐Iglesias, Giovanna Maria Stanfoca Casagrande, Daniel García‐Lojo, Letícia Ferro Leal, Tien Anh Ngo, Jorge Pérez‐Juste, Rui Manuel Reis, Krishna Kant, Isabel Pastoriza Santos
Discussion(0)
No comments yet. Be the first to comment.